Aidapak Recalls Ascorbic Acid Tablets Due to Potential Labeling Error
Aidapak Services, LLC is recalling 500 mg Ascorbic Acid tablets that may be mislabeled as Febuxostat 40 mg. The error could lead to incorrect medication administration.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Ascorbic Acid Tablets, 500 mg, Over The Counter, NDC 60258014101. The recall is due to a labeling mixup where the product may be mislabeled as Febuxostat, Tablet, 40 mg, NDC 64764091830.
The affected product is identified by the pedigree AD23082_19 and an expiration date of 5/6/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The mislabeling presents a risk that patients or healthcare providers might administer the wrong medication.
Consumers and healthcare providers should check their inventory for Ascorbic Acid Tablets, 500 mg, with the specified pedigree and expiration date. If the product is found, it should be returned to the distributor or disposed of according to local regulations. The FDA classifies this as a Class II recall, indicating a situation that might cause temporary or medically reversible health consequences.
The recalled product
- Product
- ASCORBIC ACID Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 60258014101
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- ASCORBIC ACID Tablet
- 500 mg has the following code Pedigree: AD23082_19
- EXP: 5/6/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Ascorbic Acid Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Ascorbic Acid Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateCalcium Acetate Tablets Recalled for Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateDesloratadine Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mercaptopurine Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Rosuvastatin Calcium Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29